InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Gold Lawrence Marshall, 董事. Director active across 1 company, notably 180 Life Sciences Corp.. Aggregated, 6 reports have been logged. Activity tracked since 4 August 2021. The latest transaction was disclosed on 4 September 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gold Lawrence Marshall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
21,455 股0Common StockSEC:0001213900-23-074490:0
30,702 股0Common StockSEC:0001213900-22-068724:0
13,068 股0Common StockSEC:0001213900-22-058482:0
10,570 股@ US$1.3624.4% 占其流量Common StockSEC:0001213900-22-028976:0
4,728 股@ US$3.0422.5% 占其流量Common StockSEC:0001213900-22-002421:0
4,629 股@ US$7.5653.1% 占其流量Common StockSEC:0001213900-21-040776:0
6 条申报中的 6 条
About Gold Lawrence Marshall
Lawrence Marshall Gold is a Director at 180 Life Sciences Corp. He plays a key role in the governance of the company, contributing to strategic decision-making and the overall direction of the organization. With a strong background in the industry, he brings valuable expertise to the board. His commitment to best practices in corporate governance is essential for ensuring transparency and accountability within the organization.
